5-HIAA in Cerebrospinal Fluid and Deficit Schizophrenic Characteristics
- 1 April 1990
- journal article
- research article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 156 (4) , 501-507
- https://doi.org/10.1192/bjp.156.4.501
Abstract
Higher CSF 5-HIAA concentrations and lower CSF HVA concentrations have been associated with various measures of slowed motor behaviour and communication in schizophrenic patients. To derive a single, reliable measure of deficit characteristics in schizophrenic patients, we entered four items of the BPRS reflecting negative symptoms, a work history measure derived from the Strauss-Carpenter scale, and three subscale scores of the WAIS-R into a principal-components analysis to derive a single factor score. The CSF 5-HIAA concentrations were within the normal range of values, and correlated directly with this factor score, but CSF HVA concentrations were not associated with the deficit factor score. These findings add support to the hypothesis that brain serotonin function is associated with deficit schizophrenic characteristics.This publication has 31 references indexed in Scilit:
- Rating scales in research: The case of negative symptomsPsychiatry Research, 1987
- Pilot study on the effects of fenfluramine on negative symptoms in twelve schizophrenic inpatientsBiological Psychiatry, 1985
- Low HVA and normal 5HIAA CSF levels in drug-free schizophrenic patients compared to healthy volunteers: Correlations to symptomatology and family historyPsychiatry Research, 1985
- Serotonin and schizophrenia: Correlations between serotonergic activity and schizophrenic motor behaviorPsychiatry Research, 1985
- Factor analysis of the WAIS—R: Psychiatric and standardization samples.Journal of Consulting and Clinical Psychology, 1984
- CSF 5-HIAA AND SUICIDE IN NON-DEPRESSED SCHIZOPHRENICSThe Lancet, 1983
- Factor analysis of the WAIS-R at nine age levels between 16 and 74 years.Journal of Consulting and Clinical Psychology, 1983
- CSF monoamine metabolites in schizophrenic patientsActa Psychiatrica Scandinavica, 1982
- Molecular pathology of schizophrenia: more than one disease process?BMJ, 1980
- Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in psychiatric patientsInternational Journal of Neuropharmacology, 1969